Natco Pharma Limited has informed the Exchange regarding a press release dated November 21, 2025, titled "Conclusion of FDA Inspection at our Manali, Chennai API Unit".
Natco Pharma Limited has informed the Exchange regarding a press release dated November 21, 2025, titled "Conclusion of FDA Inspection at our Manali, Chennai API Unit".